News

Researchers have found a compound that may treat inflammatory bowel disease (IBD) without directly targeting inflammation. The compound tamps down the activity of a gene linked to blood clotting.

Researchers report in Nature why the liver is the most common site of metastatic disease. Their research shows that hepatocytes coordinate myeloid cell accumulation and liver fibrosis (the thickening and scarring of tissue) which increases the organ’s susceptibility to cancer cells.

Scientists have identified a genetic mechanism that may play a role in at least 10 percent of all obesity cases.

Through the use of resting-state functional magnetic resonance imaging, reproducible brain connectivity patterns were identified in people with autism. However, as these phenotypes were only moderately linked to clinical symptoms, the usability of this imaging alone is limited as a diagnostic tool.

The Pistoia Alliance, a global not-for-profit that works to lower barriers to innovation in life sciences R&D, today released proof of concept (PoC) software to enable the digitisation of analytical method descriptions, as part of its Method Database (MethodDB) project.

Researchers have discovered a mechanism that gives human cells a chance to stop piling up mutations when cells replicate and divide in the body.

In a new study, published today researchers reveal a novel and unexpected function of sleep that they believe could explain how sleep and sleep disturbances affect brain performance, aging and various brain disorders.

Some parents who smoke at home can be nudged outdoors with a combination of coaching, lights and sound using technology that detects secondhand smoke in the house.

Scientists have developed a biosensor that expresses biomaterials’ colors using nano structure and applies a new image signal processing technique which could give insights into disease processes inside cells or organs.

Researchers have set themselves the task of immunizing camels with pollen allergens to obtain heavy single-chain antibodies for the passive treatment of pollen allergies, which affects one in five Austrians.